Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 132

1.

Evaluating drug-drug interaction information in NDF-RT and DrugBank.

Peters LB, Bahr N, Bodenreider O.

J Biomed Semantics. 2015 May 11;6:19. doi: 10.1186/s13326-015-0018-0. eCollection 2015.

2.

Exploring adverse drug events at the class level.

Winnenburg R, Sorbello A, Bodenreider O.

J Biomed Semantics. 2015 May 1;6:18. doi: 10.1186/s13326-015-0017-1. eCollection 2015.

3.

Using description logics to evaluate the consistency of drug-class membership relations in NDF-RT.

Winnenburg R, Mortensen JM, Bodenreider O.

J Biomed Semantics. 2015 Mar 28;6:13. doi: 10.1186/s13326-015-0007-3. eCollection 2015.

4.

Don't Like RDF Reification? Making Statements about Statements Using Singleton Property.

Nguyen V, Bodenreider O, Sheth A.

Proc Int World Wide Web Conf. 2014 Apr 11;2014:759-770.

5.

MaPLE: A MapReduce Pipeline for Lattice-based Evaluation and Its Application to SNOMED CT.

Zhang GQ, Zhu W, Sun M, Tao S, Bodenreider O, Cui L.

Proc IEEE Int Conf Big Data. 2014 Oct;2014:754-759.

6.

Context-driven automatic subgraph creation for literature-based discovery.

Cameron D, Kavuluru R, Rindflesch TC, Sheth AP, Thirunarayan K, Bodenreider O.

J Biomed Inform. 2015 Apr;54:141-57. doi: 10.1016/j.jbi.2015.01.014. Epub 2015 Feb 7.

PMID:
25661592
7.

A time-indexed reference standard of adverse drug reactions.

Harpaz R, Odgers D, Gaskin G, DuMouchel W, Winnenburg R, Bodenreider O, Ripple A, Szarfman A, Sorbello A, Horvitz E, White RW, Shah NH.

Sci Data. 2014 Nov 11;1:140043.

8.

A framework for assessing the consistency of drug classes across sources.

Winnenburg R, Bodenreider O.

J Biomed Semantics. 2014 Jul 9;5:30. doi: 10.1186/2041-1480-5-30. eCollection 2014.

9.

Metrics for assessing the quality of value sets in clinical quality measures.

Winnenburg R, Bodenreider O.

AMIA Annu Symp Proc. 2013 Nov 16;2013:1497-505. eCollection 2013.

10.

From concept representations to ontologies: a paradigm shift in health informatics?

Schulz S, Balkanyi L, Cornet R, Bodenreider O.

Healthc Inform Res. 2013 Dec;19(4):235-42. doi: 10.4258/hir.2013.19.4.235. Epub 2013 Dec 31. Review.

11.

Desiderata for an authoritative Representation of MeSH in RDF.

Winnenburg R, Bodenreider O.

AMIA Annu Symp Proc. 2014 Nov 14;2014:1218-27. eCollection 2014.

12.

Coverage of rare disease names in standard terminologies and implications for patients, providers, and research.

Fung KW, Richesson R, Bodenreider O.

AMIA Annu Symp Proc. 2014 Nov 14;2014:564-72. eCollection 2014.

13.

Analyzing U.S. prescription lists with RxNorm and the ATC/DDD Index.

Bodenreider O, Rodriguez LM.

AMIA Annu Symp Proc. 2014 Nov 14;2014:297-306. eCollection 2014.

14.

The NLM value set authority center.

Bodenreider O, Nguyen D, Chiang P, Chuang P, Madden M, Winnenburg R, McClure R, Emrick S, D'Souza I.

Stud Health Technol Inform. 2013;192:1224.

15.

Medical concept representation: the years beyond 2000.

Balkanyi L, Schulz S, Cornet R, Bodenreider O.

Stud Health Technol Inform. 2013;192:1011.

16.

Exploring pharmacoepidemiologic groupings of drugs from a clinical perspective.

Winnenburg R, Bodenreider O.

Stud Health Technol Inform. 2013;192:827-31.

17.

Enabling complex queries to drug information sources through functional composition.

Peters L, Mortensen J, Nguyen T, Bodenreider O.

Stud Health Technol Inform. 2013;192:692-6.

18.

Leveraging terminological resources for mapping between rare disease information sources.

Rance B, Snyder M, Lewis J, Bodenreider O.

Stud Health Technol Inform. 2013;192:529-33.

19.

Quality assurance in LOINC using Description Logic.

Adamusiak T, Bodenreider O.

AMIA Annu Symp Proc. 2012;2012:1099-108. Epub 2012 Nov 3.

20.

Issues in creating and maintaining value sets for clinical quality measures.

Winnenburg R, Bodenreider O.

AMIA Annu Symp Proc. 2012;2012:988-96. Epub 2012 Nov 3.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk